List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #931 to #980.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ARBsAngiotensin II receptor antagonist
  2. ARCHAmiodarone Reduction In Coronary Heart Trial
  3. ARCHeRFor Revascularization Of Carotids In High-Risk Patients
  4. ARDSAcute respiratory distress syndrome
  5. AREDSAge-Related Eye Disease Study
  6. ARFAcute kidney injury
  7. ARG-911Argatroban-911
  8. ARG-915Argatroban-915
  9. ARGAMI-2Argatroban For Acute Myocardial Infarction
  10. ARICAtherosclerosis Risk In Communities
  11. ARIES 1 and 2Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
  12. ARISEAggressive Reduction Of Inflammation Stops Events
  13. ARI Sodium Iodide (I123) 1-12 MBqSodium iodide
  14. ARI Sodium Iodide (I123) 100-750 MBqSodium iodide
  15. ARMSApsac Reocclusion Multicenter Study
  16. ARMYDAAtorvastatin For Reduction Of Myocardial Damage During Angioplasty
  17. ARMYDA-2Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
  18. ARMYDA-3Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
  19. ARMYDA-4Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
  20. ARMYDA-5Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
  21. ARMYDA-ACSAtorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
  22. ARMYDA-RECAPTUREAtorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
  23. ARMYDA-RELOADAntiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
  24. ARNT geneAryl hydrocarbon receptor nuclear translocator
  25. ARPEGGIORimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
  26. ARPKDPolycystic kidney disease
  27. ARRAbsolute risk reduction
  28. ARTAIDS antiretroviral drugs
  29. ARTISTAngioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
  30. ARTISTICAngiorad Radiation Therapy For In-Stent Restenosis Intracoronary
  31. ARTSArterial Revascularization Therapies Study
  32. ARTS-IIArterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
  33. ARTS I - Five year follow-upFive Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
  34. ARVCArrhythmogenic right ventricular dysplasia
  35. ARVDArrhythmogenic right ventricular dysplasia
  36. ARVD/CArrhythmogenic right ventricular dysplasia
  37. AR DeficiencyAndrogen insensitivity syndrome
  38. AR deficiencyAndrogen insensitivity syndrome
  39. ASAAspirin
  40. ASAPEffect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
  41. ASA physical status classConscious sedation#ASA Physical Status Classification
  42. ASA physical status classificationConscious sedation#ASA Physical Status Classification
  43. ASCENTAcs Stent Clinical Equivalence In De Novo Lesions Trial
  44. ASCOTAnglo-Scandinavian Cardiac Outcome Trial
  45. ASCOT-LLA TrialASCOT-LLA
  46. ASCOT - Blood Pressure ArmAnglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
  47. ASCOT - Lipid ArmASCOT-LLA
  48. ASCVDCAD
  49. ASDAtrial septal defect
  50. ASFASTAtherosclerosis And Folic Acid Supplementation Trial

View ( | ) (20 | 50 | 100 | 250 | 500)